z-logo
open-access-imgOpen Access
Antibacterial resistance in Helicobacter pylori strains isolated from Bulgarian children and adult patients over 9 years
Author(s) -
Lyudmila Boyanova,
Rossen Nikolov,
Elena Lazarova,
Galina Gergova,
Nikolai Katsarov,
Victor Kamburov,
Zoya Spassova,
Sirigan Derejian,
Christo Jelev,
Ivan Mitov,
Zacharii Krastev
Publication year - 2005
Publication title -
journal of medical microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.91
H-Index - 117
eISSN - 1473-5644
pISSN - 0022-2615
DOI - 10.1099/jmm.0.46208-0
Subject(s) - clarithromycin , metronidazole , amoxicillin , helicobacter pylori , medicine , agar dilution , tetracycline , antibiotic resistance , microbiology and biotechnology , antibiotics , antibacterial agent , minimum inhibitory concentration , biology
The aim of this study was to evaluate the primary, combined and post-treatment antibacterial resistance rates in 1205 Helicobacter pylori strains from non-treated (786 adults, 282 children) and treated (109 adults, 28 children) patients in Bulgaria. Susceptibility was tested by the limited agar dilution method. Overall primary resistance rates to metronidazole, clarithromycin, amoxicillin, tetracycline and both metronidazole and clarithromycin were respectively 15.0, 12.5, 1.5, 3.4 and 4.7% in children and 25.6, 12.6, 0.8, 5.2 and 4.9% in adults. Primary metronidazole resistance in adults was more common than in children, but the differences for other agents tested were not significant. Primary resistance rates were in the range of those reported worldwide. There was no significant increase in primary resistance rates from 1996/1999 to 2003/2004; however, clarithromycin resistance rates exhibited a slight tendency to increase. Post-treatment resistance to amoxicillin was detected in 1.6% of 63 strains. Post-treatment resistance to metronidazole was common (81.6%) and that to clarithromycin was considerable (36%). Alarming emergence of strains with triple resistance to amoxicillin, metronidazole and clarithromycin was found in two non-treated and three treated patients. The results motivate a larger and continuing surveillance of H. pylori resistance in Bulgaria and worldwide.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom